Takashi Tamai
African Studies Association 68th Annual Meeting 2025年11月21日 African Studies Association
During the COVID-19 pandemic, vaccine distribution was one of the key technological factors in defending society against pathogens. However, the distribution of the vaccine in Africa is said to have been unequal, despite reflections on the past distribution of HIV/AIDS drugs and considerable efforts by the international community. This presentation first examines the political-economic mechanisms surrounding the inequitable distribution of COVID-19 vaccines in Africa. Underlying this problem are the barriers to intellectual property rights for vaccines and drugs and the assumption that international policy is based on the premise that Africa is the beneficiary and not the developer of technological goods. Second, the presentation explores the potential challenges in African-led vaccine production. Technology transfer for vaccine R&D and the establishment of a vaccine manufacturing base are already underway in other African countries, including the mRNA vaccine technology transfer hub in South Africa. My analysis is based on documents issued by international organizations, nongovernmental organizations (NGOs), and pharmaceutical companies, as well as data collected through interviews with NGOs in South Africa. Exploring the opportunities and challenges of African-led vaccine production is becoming increasingly important as the United States refuses to continue playing a role in global health.